<DOC>
	<DOCNO>NCT00270725</DOCNO>
	<brief_summary>The purpose study determine impact anti-HIV treatment work attendance employ people South Africa . The study enroll participant large manufacture distribution firm South Africa .</brief_summary>
	<brief_title>Impact Anti-HIV Treatment Labor Productivity Costs South Africa</brief_title>
	<detailed_description>Little known economic benefit provide antiretroviral therapy ( ART ) HIV infected patient sub-Saharan Africa resource-limited area . In South Africa , increase number private sector firm provide access ART employee . One barrier action , however , lack available information success ART restore worker full productivity , retain skilled employee workforce , reduce cost medical care death disability benefit . HIV infect employee ART may absent work less often untreated HIV infect employee , often HIV uninfected employee . This study collect data independent HIV/AIDS disease treatment program large private sector employer Johannesburg , South Africa estimate benefit cost business provide ART eligible employee . The study combine individual-level medical outcome treatment cost data treatment program data employee work attendance retention workforce participate employer . The work attendance HIV infect employee enrol HIV/AIDS treatment program ( index participant ) either take ART receive pre-ART care compare HIV uninfected employee . There study visit associate study ; data collect medical record maintain HIV/AIDS treatment program participant ' employer . The financial cost benefit treatment program participate company also estimate .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria All Participants : Employed participate company least 1 year prior study entry Inclusion Criteria Index Participants : Enrolled HIV/AIDS treatment program offer participate company Exclusion Criteria Index Participants : Enrolled HIV/AIDS treatment program prior 01/01/04 06/30/05</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Labor productivity</keyword>
	<keyword>Antiretroviral therapy</keyword>
	<keyword>South Africa</keyword>
</DOC>